{"transactions":[{"id":831863,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Prabhu Narayan","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-20T21:00:47.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":40925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option award was made on March 18, 2026 (the \"Grant Date\") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The option provides for vesting as follows: (i) 12,789 of the shares subject to the option are immediately vested on the Grant Date, and (ii) 28,136 shares subject to the option will vest in equal installments on the last day of each month from April 2026 to December 2028. The exercise price is based on the closing price of the Issuer's common stock, par value $0.0001 per share, on the Grant Date in accordance with the terms of the 2020 Plan."}],"balance_after":40925,"derivative":{"exercise_price":1.87,"expiration_date":"2036-03-17","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":40925},"source":{"system":"sec-edgar","filing":"0001437749-26-009260","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774926009260/rdgdoc.xml","form_type":"4"}},{"id":1263198,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:30:51.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":194250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made on February 13, 2025 (the \"Grant Date\") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The option provides for vesting as follows: (i) 80,938 of the shares subject to the option are immediately vested on the Grant Date, (ii) 89,043 shares subject to the option will vest in equal installments on the last day of each month from March 2025 to December 2026, and (iii) 24,269 shares subject to the option will vest in equal installments on the last day of each month from January 2027 to December 2027. The exercise price is based on the closing price of the Issuer's common stock, par value $0.0001 per share, on the Grant Date in accordance with the terms of the 2020 Plan."}],"balance_after":194250,"derivative":{"exercise_price":1.8,"expiration_date":"2035-02-12","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":194250},"source":{"system":"sec-edgar","filing":"0001437749-25-004221","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774925004221/rdgdoc.xml","form_type":"4"}},{"id":1404508,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-17T21:01:27.000Z","date":"2024-09-15","kind":"grant","planned":false,"acquired":true,"shares":96519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an option award (the \"Option\") granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the \"Reporting Person\"), by the Issuer's compensation committee (the \"Compensation Committee\") on September 15, 2024 (the \"Grant Date\") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). On the Grant Date, the Compensation Committee determined the amount of incentive bonus earned by Mr. Prabhu for 2023 and determined that the Issuer would pay the incentive bonus in the form of fully vested options in lieu of cash payment. The Option, which is fully vested on the Grant Date, represents payment of Mr. Prabhu's incentive bonus earned for 2023. The exercise price of the Option is based on the closing price of the Issuer's common stock on September 13, 2024, in accordance with the terms of the 2020 Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option award (the \"Option\") granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the \"Reporting Person\"), by the Issuer's compensation committee (the \"Compensation Committee\") on September 15, 2024 (the \"Grant Date\") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). On the Grant Date, the Compensation Committee determined the amount of incentive bonus earned by Mr. Prabhu for 2023 and determined that the Issuer would pay the incentive bonus in the form of fully vested options in lieu of cash payment. The Option, which is fully vested on the Grant Date, represents payment of Mr. Prabhu's incentive bonus earned for 2023. The exercise price of the Option is based on the closing price of the Issuer's common stock on September 13, 2024, in accordance with the terms of the 2020 Plan."}],"balance_after":96519,"derivative":{"exercise_price":1.2,"expiration_date":"2034-09-14","underlying":"Common Stock, par value $0.0001 per shae","underlying_shares":96519},"source":{"system":"sec-edgar","filing":"0001437749-24-029387","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774924029387/rdgdoc.xml","form_type":"4"}},{"id":1912026,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-04-27T20:30:21.000Z","date":"2023-04-25","kind":"grant","planned":false,"acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option award granted to Mr. Narayan Prabhu, the Issuer's Chief Financial Officer (the \"Reporting Person\"), by the Issuer's compensation committee on April 25, 2023 (the \"Grant Date\") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan."}],"balance_after":170000,"derivative":{"exercise_price":6.74,"expiration_date":"2033-04-24","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001437749-23-011378","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774923011378/rdgdoc.xml","form_type":"4"}},{"id":2146924,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-10-03T21:01:57.000Z","date":"2022-09-30","kind":"purchase","acquired":true,"shares":50000,"price":1.66,"value":83000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001437749-22-023485","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922023485/rdgdoc.xml","form_type":"4"}},{"id":2218470,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-06-30T21:52:37.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":50000,"price":1.2134,"value":60670.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.08 to $1.37 per share, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-22-016306","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774922016306/rdgdoc.xml","form_type":"4"}},{"id":2748193,"issuer":{"id":8147,"kind":"organization","name":"REVIVA PHARMACEUTICALS HOLDINGS, INC."},"owners":[{"id":56787,"kind":"person","name":"Prabhu Narayan","position":1,"cik":"0001829831","reported_name":"Narayan Prabhu","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-15T21:09:39.000Z","date":"2021-04-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the \"2020 Plan\"). The Option will vest at the rate of twenty-five percent (25%) of the shares subject thereto upon the one year anniversary of Mr. Prabhu's employment with the Company, and as to an additional 2.0833% of the shares on the last day of each month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2020 Plan."}],"balance_after":50000,"derivative":{"exercise_price":4.3,"expiration_date":"2031-04-13","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-009050","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1742927/000143774921009050/rdgdoc.xml","form_type":"4"}}]}